Worldwide Diagnostic Biochips Industry Report 2022: Emerging Microfluidic Biochip Fabrication Technologies Focusing on High-throughput Production – Yahoo Finance

Dublin, Nov. 14, 2022 (GLOBE NEWSWIRE) — The “Technological Innovations and Growth Opportunities in Diagnostic Biochips” report has been added to ResearchAndMarkets.com’s offering.
Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments.
To overcome this need, diagnostic biochip technology offers a miniaturized multiplexing sensing platform. A biochip is a solid substrate with a multitude of miniaturized test sites that have immobilized probes to capture and detect the target biomolecules. While biochips can have several applications, current research focuses on diagnostic biochips.
The huge demand for precision medicine and low-cost point-of-care diagnostic platforms will drive the market. However, key players must focus on reducing the costs of DNA and protein biochips, meeting regulatory standards, and increasing awareness among users.
The global diagnostic biochips industry is advancing, offering new fluidic control technologies, probe immobilization techniques, signal detection technologies, and data analytics. As they can detect different kinds of biomolecules, innovative diagnostic biochips provide growth opportunities for genetic testing, cancer diagnostics and therapy, infectious diseases management, chronic disease management, allergy panel testing, and drug testing. This study focuses on DNA biochips, protein biochips, and microfluidic biochips.
The key elements of this analysis include an overview of the global diagnostic biochips industry supported by the following:
Technology advantages and disadvantages
Industry growth drivers and restraints
Key participants in different industry segments
Technology roadmap
SWOT analysis of diagnostic biochips
Adoption, funding, and M&A trends
Impact of the different technology segments
Patent filing trends
Growth opportunities for key companies
Key Topics Covered:
1. Strategic Imperatives
2. Growth Opportunity Analysis
Diagnostic Biochips for Miniature and Multiplexing Biosensing Devices
Diagnostic Biochips Are Advancing with New Microarray Formats and Fabrication Technologies
Biochips as Miniature Devices Enable High-throughput Testing
Biochips Have a Multitude of Applications
Segmentation
Increasing Demand for Personalized Medicine as a Growth Driver for Diagnostic Biochips Industry
High Costs as a Growth Restraint for Diagnostic Biochips Industry
Diagnostic Biochips Industry as a Growing and Fragmented Market
Scope of Analysis
3. Technology Analysis: DNA Biochips
DNA Biochips Enabling Detection of Genetic Biomarkers of Disease
Emerging DNA Biochip Fabrication Technologies Aiming for Low Device Costs
Diagnostic DNA Biochips Have High Impact on Biomarkers Discovery
DNA Biochips – Competitive Environment
4. Technology Analysis: Protein Biochips
Protein Biochips for Protein Profiling, Disease Biomarkers Detection, and Protein Functions Identification
Emerging Protein Biochip Fabrication Technologies Focusing on High Sensitivity and Immobilization Efficiency
Diagnostic Protein Biochips Have High Impact on Biomarkers Discovery
Protein Biochips – Competitive Environment
5. Technology Analysis: Microfluidic Biochips
Microfluidic Biochips for Disease Diagnosis at POC
Emerging Microfluidic Biochip Fabrication Technologies Focusing on High-throughput Production
Diagnostic Microfluidic Biochips Have High Impact on Identification of Nucleic Acid and Protein Biomarkers
Microfluidic Biochips – Competitive Environment
6. Innovation Indicators
Microfluidic Diagnostic Biochips Segment Exhibits High Technology Evolution and Adoption Trends
Low Cost and Portability of Microfluidic Biochips Attracting Research
Microfluidics for Low-cost Multiplexing LOC Devices
Diagnostic Biochip Technology Advancing toward In Vivo Continuous Monitoring Devices
Microfluidic Biochips Excel in Portability, Cost Efficiency, and Ease of Fabrication
Recent M&A Activity Analysis, 2019-2022
Government Funding Analysis, 2019-2022
Private Funding Activities Snapshot, 2019-2022
7. Patent Analysis
Innovation Themes Include Microfluidic and Microarray Designs and Data Processing Technologies
Key Patents
8. Growth Opportunity Universe
Growth Opportunity 1: Molecular Electronics
Growth Opportunity 2: Micro-electrode-dot Array (MEDA) Biochips
Growth Opportunity 3: Intelligent Biochip Platform
9. Key Industry Participants
10. Appendix
12. Next Steps
For more information about this report visit https://www.researchandmarkets.com/r/1bw8qc

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The shares are down sharply from its 2021 zenith but the charts have improved in recent months.
The facility, bought from a Novartis unit, will be its first messenger ribonucleic acid, or mRNA, facility in Singapore and support its vaccines production for the Asia Pacific region, BioNTech said in a statement, without disclosing financial details. MRNA vaccines, which scientists say trick the body into protecting itself against an illness by copying viral proteins, are seen as a safe, speedy alternative to traditional vaccines – especially during a pandemic – since they involve no exposure to the illness.
“Northern Maine is full of amazing geologic wonders.”
Two days before US president Joe Biden and Chinese leader Xi Jingping held a frosty confab in Bali, a secret, autonomous spacecraft descended from its orbit hundreds of miles above the planet to land at Cape Canaveral.
NUSA DUA, Indonesia (Reuters) -Billionaire Elon Musk said on Monday he was working "at the absolute most amount…from morning til night, seven days a week" when asked about his recent acquisition of Twitter and his leadership of automaker Tesla Inc. "I have too much work on my plate that is for sure," Musk said by videolink to a business conference on the sidelines of the G20 summit in Bali. Musk is chief executive of both companies and also runs rocket firm SpaceX, brain-chip startup Neuralink and tunneling firm the Boring Company.
Treasury Metals Inc. (TSX: TML) (OTCQX: TSRMF) ("Treasury Metals" or the "Company") is pleased to announce results on two exploration targets from the Goldlund property tested during the 2021 and 2022 drill campaigns. The first program, consisting of seven holes (1,458 metres), was to follow-up on a new target (TTG) located to the northwest of the Goldlund PEA pit design. Additionally, the Company released four follow-up holes (1,380 metres) from the Wild Cat exploration program testing the cont
With the successful completion of its sixth mission, the reusable spaceplane has now flown over 1.3 billion miles and spent a total of 10 years in space.
The best funds are the First Trust NYSE Arca Biotechnology Index Fund, Invesco Dynamic Biotechnology & Genome ETF, and VanEck Biotech ETF.
STORY: Musk, the chief executive of both companies, was speaking via videolink from a place he said had just lost power. He appeared lit by candles, wearing a batik shirt sent by the organizers.Asked about his recent acquisition of Twitter and his leadership of automaker Tesla, Musk said he was working around the clock, saying "I have too much work on my plate that is for sure."Indonesia has been trying to secure a deal with Tesla on battery investment and potentially for Elon Musk's SpaceX aerospace company to develop a rocket launch site. Musk made no commitment to either of those but said Indonesia had a large role to play in the electric vehicle supply chain and that it would make sense "long term" for SpaceX to have multiple launch points around the globe.
By Ernest Dela Aglanu, Benzinga
FPX Nickel Corp. (TSXV: FPX) (OTCQB: FPOCF) ("FPX" or the "Company") is pleased to report an updated mineral resource estimate for the Baptiste Nickel Project ("Baptiste" or the "Project") at the Decar Nickel District ("Decar") in central British Columbia. The 2022 mineral resource estimate incorporates results from 2021's in-fill drilling program and is based on a new geological modelling approach and newly improved dike model, all of which contribute to significantly improved Davis Tube Recove
Silicon Valley startup Cerebras Systems, known in the industry for its dinner plate-sized chip made for artificial intelligence work, on Monday unveiled its AI supercomputer called Andromeda, which is now available for commercial and academic research. Andromeda is built by linking up 16 Cerebras CS-2 systems, the company's latest AI computer built around the over-sized chip called the Wafer-Scale Engine 2. Cerebras said Andromeda can perform 1 exaflop worth of AI computing – or at least one quintillion (10 to the power of 18) operations per second – based on a precision of 16 bit floating point format.
Archaeologists have unearthed amazing swords, daggers and other weaponry
I'm focused on looking for more positive chart setups and I'm not too concerned about a reversal in the market right now.
Silicon Valley artificial intelligence (AI) computing startup SambaNova Systems said on Monday it delivered eight units of its latest AI system to the U.S. Argonne National Laboratory, which is expanding its AI offering to researchers. With AI work taking center stage in research, Argonne National Laboratory has been testing out various AI chips and systems, Rick Stevens, associate lab director for computing, environment and life sciences at Argonne lab told Reuters. In addition to SambaNova, AI systems from startups including Cerebras Systems, Groq Inc, Graphcore, and Intel Corp owned Habana Labs have been tested.
A decade ago, Tunisian fisherman Ahmed Chelli's nets bulged with fish and octopus that he sold at the local market in the Kerkennah islands. Today, he pulls up only "ISIS" — the name locals have given to the blue crabs that have invaded their fishing grounds in the fast-warming waters of the Mediterranean. For more than 70 days this summer, a marine heatwave cooked the waters of the western Mediterranean.
We now know what likely caused the “sonic boom” that was heard by many Saturday morning at Florida’s Space Coast.
NASA’s Artemis program took an important step forward this weekend, with CAPSTONE finally reaching its destination—a near-rectilinear halo orbit (NRHO) around the Moon. The 55-pound cubesat will now test this promising orbit in preparation for the Gateway lunar space station.
AFP via GettyMud is a funny kind of dirt. If it was splattered on your outfit you would look around for a change of clothes, but you also might pay good money to have an aesthetician paint it on your face. As archaeologists excavating an ancient sanctuary in Tuscany recently discovered, the anti-aging properties of mud aren’t limited only to our faces. Italy’s Ministry of Culture announced last Tuesday that more than two dozen 2,300-year-old Etruscan bronze figures have been unearthed at San Cas
From escaping earth's orbit to going to the moon and beyond, rockets have powered mankind's space exploration — and a lot of these endeavors to the stars are thanks to a little-known facility in Utah.

source

Related Articles